Nakornthon Hospital PCL (BKK:NKT)
Thailand · Delayed Price · Currency is THB 3.940
+0.020 (0.51%)
At close: Jan 19, 2026
Nakornthon Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,983 | 1,986 | 2,004 | 1,937 | 1,524 | 1,346 |
Other Revenue | 34.15 | 34.49 | 33.21 | 20.43 | 17.93 | 30.98 |
| 2,017 | 2,020 | 2,037 | 1,958 | 1,542 | 1,377 | |
Revenue Growth (YoY) | -1.03% | -0.81% | 4.04% | 26.97% | 11.97% | - |
Cost of Revenue | 1,412 | 1,401 | 1,386 | 1,307 | 1,100 | 1,048 |
Gross Profit | 605.23 | 619.87 | 651.01 | 650.54 | 442.06 | 329.05 |
Selling, General & Admin | 338.72 | 322.94 | 293.13 | 257.11 | 223.22 | 226.76 |
Other Operating Expenses | - | - | - | -4.85 | -4 | - |
Operating Expenses | 338.72 | 322.94 | 293.13 | 252.26 | 219.22 | 226.76 |
Operating Income | 266.51 | 296.94 | 357.88 | 398.28 | 222.84 | 102.29 |
Interest Expense | -7.9 | -11.69 | -4.82 | -0.01 | -0.03 | -0.37 |
EBT Excluding Unusual Items | 258.61 | 285.25 | 353.06 | 398.27 | 222.81 | 101.93 |
Gain (Loss) on Sale of Assets | - | - | - | 0.51 | 0.53 | - |
Pretax Income | 258.61 | 285.25 | 353.06 | 398.78 | 223.34 | 101.93 |
Income Tax Expense | 55.13 | 51.54 | 70.77 | 77.88 | 40.1 | 13.71 |
Net Income | 203.48 | 233.7 | 282.29 | 320.91 | 183.24 | 88.22 |
Net Income to Common | 203.48 | 233.7 | 282.29 | 320.91 | 183.24 | 88.22 |
Net Income Growth | -14.18% | -17.21% | -12.03% | 75.13% | 107.70% | - |
Shares Outstanding (Basic) | 507 | 406 | 400 | 400 | 400 | 400 |
Shares Outstanding (Diluted) | 507 | 406 | 400 | 400 | 400 | 400 |
Shares Change (YoY) | 26.79% | 1.48% | - | - | - | - |
EPS (Basic) | 0.40 | 0.58 | 0.71 | 0.80 | 0.46 | 0.22 |
EPS (Diluted) | 0.40 | 0.58 | 0.71 | 0.80 | 0.46 | 0.22 |
EPS Growth | -32.31% | -18.42% | -12.03% | 75.13% | 107.70% | - |
Free Cash Flow | -294.68 | 105.34 | 211.88 | 267.3 | 308.94 | 158.18 |
Free Cash Flow Per Share | -0.58 | 0.26 | 0.53 | 0.67 | 0.77 | 0.40 |
Dividend Per Share | 0.180 | 0.180 | 1.000 | 0.250 | 0.110 | 0.050 |
Dividend Growth | -82.00% | -82.00% | 300.00% | 127.27% | 120.00% | - |
Gross Margin | 30.01% | 30.68% | 31.96% | 33.23% | 28.67% | 23.90% |
Operating Margin | 13.21% | 14.70% | 17.57% | 20.34% | 14.45% | 7.43% |
Profit Margin | 10.09% | 11.57% | 13.86% | 16.39% | 11.88% | 6.41% |
Free Cash Flow Margin | -14.61% | 5.21% | 10.40% | 13.65% | 20.04% | 11.49% |
EBITDA | 380.5 | 417.89 | 482.27 | 505.23 | 324.8 | 197.65 |
EBITDA Margin | 18.87% | 20.68% | 23.68% | 25.81% | 21.07% | 14.35% |
D&A For EBITDA | 113.99 | 120.95 | 124.39 | 106.95 | 101.96 | 95.36 |
EBIT | 266.51 | 296.94 | 357.88 | 398.28 | 222.84 | 102.29 |
EBIT Margin | 13.21% | 14.70% | 17.57% | 20.34% | 14.45% | 7.43% |
Effective Tax Rate | 21.32% | 18.07% | 20.04% | 19.53% | 17.96% | 13.45% |
Revenue as Reported | 2,017 | 2,020 | 2,037 | 1,963 | 1,552 | 1,382 |
Advertising Expenses | - | 18.27 | 18.31 | 10.26 | 10.93 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.